As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.
Related Posts
The dark reality of melatonin behind India’s USD289 million wild chase for good sleep
Synopsis Most Indians are sleep-deprived and are turning to melatonin for a better night’s rest. The global melatonin market reached…
Sun Pharma’s new drug to take on Pfizer, Eli Lilly is having a bad hair day.
Synopsis Last year, Sun Pharma infused over INR4,688 crore to buy US-based Concert Pharma. That deal gave it rights to…
What’s making GBS nerve disorder go viral in Pune
Getty Images Guillain-Barre syndrome (GBS) test, a rare disorder where the body’s immune system damages nerve Synopsis Guillain-Barré Syndrome is…
